Scotland: The AUGIS 2018 ASM will take place in Edinburgh – look our for further details soon!
There will be a Scottish Upper GI National Meeting 2017 taking place at the Learning, Education & Training Centre at the Forth Valley Royal Hospital on Friday, October 27.
Scotland: The Scottish Cancer Networks for Oesophagogastric and Hepatopancreaticobiliary cancer held separate meetings in November. The HPB meeting at the Aberdeen Royal Infirmary included analysis of the surgical audit for 2015. It was well-attended meeting and included presentations on the management of pancreatic lesions and trial updates among other topics.
The oesophagogastric meeting at Perth Royal Infirmary was attended by all interested specialities and included a review of the Quality Performance Indicators for 2015. External opinion was provided by Professor Bill Allum from the Royal Marsden. As in previous years, issues highlighted included the lack of resource for dietetics and regional variations in curative treatments offered to oesophageal cancer patients. The issue of positive CRM in patients undergoing oesophagectomy is to be reviewed across the regions. The QPI reports for the two specialities are available on the Scottish Cancer Network website.
North Thames: Over the last two years there has been a major re-configuration of cancer services in North, North East London and West Essex, which make up London Cancer, covering a population of 3.2 million. This included oesophagogastric cancer surgery with the merger of the surgical units at UCLH and The Royal London Hospital at UCLH in December 2015. One year on, the new centre, based on a hub and spoke model, is working well and providing excellent training. The centre is tracking outcomes but the centralisation of OG and urological cancer services in London Cancer and Manchester Cancer is also part of the RESPECT-21 (reorganising specialist cancer surgery for the 21st century: a mixed methods evaluation) study which will report in a few years.
An oesophageal anastomosis workshop was held at UCLH in June 2016, under the auspices of the UGI Collaborative. It was attended by 12 consultants and 9 trainees. In September, a symposium on recent advances in benign oesophageal disease was held at Imperial College, London. It was attended by 42 delegates. Feedback was excellent for both meetings.